Eintrag weiter verarbeiten
20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways
Gespeichert in:
| Zeitschriftentitel: | Frontiers in Pharmacology |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | Frontiers in Pharmacology, 9, 2019 |
| Format: | E-Article |
| Sprache: | Unbestimmt |
| veröffentlicht: |
Frontiers Media SA
|
| Schlagwörter: |
| author_facet |
Pan, Chenhao Shan, Haojie Wu, Tianyi Liu, Wei Lin, Yiwei Xia, Wenyang Wang, Feng Zhou, Zubin Yu, Xiaowei Pan, Chenhao Shan, Haojie Wu, Tianyi Liu, Wei Lin, Yiwei Xia, Wenyang Wang, Feng Zhou, Zubin Yu, Xiaowei |
|---|---|
| author |
Pan, Chenhao Shan, Haojie Wu, Tianyi Liu, Wei Lin, Yiwei Xia, Wenyang Wang, Feng Zhou, Zubin Yu, Xiaowei |
| spellingShingle |
Pan, Chenhao Shan, Haojie Wu, Tianyi Liu, Wei Lin, Yiwei Xia, Wenyang Wang, Feng Zhou, Zubin Yu, Xiaowei Frontiers in Pharmacology 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways Pharmacology (medical) Pharmacology |
| author_sort |
pan, chenhao |
| spelling |
Pan, Chenhao Shan, Haojie Wu, Tianyi Liu, Wei Lin, Yiwei Xia, Wenyang Wang, Feng Zhou, Zubin Yu, Xiaowei 1663-9812 Frontiers Media SA Pharmacology (medical) Pharmacology http://dx.doi.org/10.3389/fphar.2018.01538 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways Frontiers in Pharmacology |
| doi_str_mv |
10.3389/fphar.2018.01538 |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM4OS9mcGhhci4yMDE4LjAxNTM4 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM4OS9mcGhhci4yMDE4LjAxNTM4 |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Frontiers Media SA, 2019 |
| imprint_str_mv |
Frontiers Media SA, 2019 |
| issn |
1663-9812 |
| issn_str_mv |
1663-9812 |
| language |
Undetermined |
| mega_collection |
Frontiers Media SA (CrossRef) |
| match_str |
pan201920sprotopanaxadiolinhibitstitaniumparticleinducedinflammatoryosteolysisandranklmediatedosteoclastogenesisviamapkandnfkbsignalingpathways |
| publishDateSort |
2019 |
| publisher |
Frontiers Media SA |
| recordtype |
ai |
| record_format |
ai |
| series |
Frontiers in Pharmacology |
| source_id |
49 |
| title |
20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_unstemmed |
20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_full |
20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_fullStr |
20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_full_unstemmed |
20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_short |
20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_sort |
20(s)-protopanaxadiol inhibits titanium particle-induced inflammatory osteolysis and rankl-mediated osteoclastogenesis via mapk and nf-κb signaling pathways |
| topic |
Pharmacology (medical) Pharmacology |
| url |
http://dx.doi.org/10.3389/fphar.2018.01538 |
| publishDate |
2019 |
| physical |
|
| description |
|
| container_start_page |
0 |
| container_title |
Frontiers in Pharmacology |
| container_volume |
9 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792339029493022720 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:41:37.997Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=20%28S%29-Protopanaxadiol+Inhibits+Titanium+Particle-Induced+Inflammatory+Osteolysis+and+RANKL-Mediated+Osteoclastogenesis+via+MAPK+and+NF-%CE%BAB+Signaling+Pathways&rft.date=2019-01-18&genre=article&issn=1663-9812&volume=9&jtitle=Frontiers+in+Pharmacology&atitle=20%28S%29-Protopanaxadiol+Inhibits+Titanium+Particle-Induced+Inflammatory+Osteolysis+and+RANKL-Mediated+Osteoclastogenesis+via+MAPK+and+NF-%CE%BAB+Signaling+Pathways&aulast=Yu&aufirst=Xiaowei&rft_id=info%3Adoi%2F10.3389%2Ffphar.2018.01538&rft.language%5B0%5D=und |
| SOLR | |
| _version_ | 1792339029493022720 |
| author | Pan, Chenhao, Shan, Haojie, Wu, Tianyi, Liu, Wei, Lin, Yiwei, Xia, Wenyang, Wang, Feng, Zhou, Zubin, Yu, Xiaowei |
| author_facet | Pan, Chenhao, Shan, Haojie, Wu, Tianyi, Liu, Wei, Lin, Yiwei, Xia, Wenyang, Wang, Feng, Zhou, Zubin, Yu, Xiaowei, Pan, Chenhao, Shan, Haojie, Wu, Tianyi, Liu, Wei, Lin, Yiwei, Xia, Wenyang, Wang, Feng, Zhou, Zubin, Yu, Xiaowei |
| author_sort | pan, chenhao |
| container_start_page | 0 |
| container_title | Frontiers in Pharmacology |
| container_volume | 9 |
| description | |
| doi_str_mv | 10.3389/fphar.2018.01538 |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM4OS9mcGhhci4yMDE4LjAxNTM4 |
| imprint | Frontiers Media SA, 2019 |
| imprint_str_mv | Frontiers Media SA, 2019 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1663-9812 |
| issn_str_mv | 1663-9812 |
| language | Undetermined |
| last_indexed | 2024-03-01T15:41:37.997Z |
| match_str | pan201920sprotopanaxadiolinhibitstitaniumparticleinducedinflammatoryosteolysisandranklmediatedosteoclastogenesisviamapkandnfkbsignalingpathways |
| mega_collection | Frontiers Media SA (CrossRef) |
| physical | |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | Frontiers Media SA |
| record_format | ai |
| recordtype | ai |
| series | Frontiers in Pharmacology |
| source_id | 49 |
| spelling | Pan, Chenhao Shan, Haojie Wu, Tianyi Liu, Wei Lin, Yiwei Xia, Wenyang Wang, Feng Zhou, Zubin Yu, Xiaowei 1663-9812 Frontiers Media SA Pharmacology (medical) Pharmacology http://dx.doi.org/10.3389/fphar.2018.01538 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways Frontiers in Pharmacology |
| spellingShingle | Pan, Chenhao, Shan, Haojie, Wu, Tianyi, Liu, Wei, Lin, Yiwei, Xia, Wenyang, Wang, Feng, Zhou, Zubin, Yu, Xiaowei, Frontiers in Pharmacology, 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways, Pharmacology (medical), Pharmacology |
| title | 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_full | 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_fullStr | 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_full_unstemmed | 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_short | 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| title_sort | 20(s)-protopanaxadiol inhibits titanium particle-induced inflammatory osteolysis and rankl-mediated osteoclastogenesis via mapk and nf-κb signaling pathways |
| title_unstemmed | 20(S)-Protopanaxadiol Inhibits Titanium Particle-Induced Inflammatory Osteolysis and RANKL-Mediated Osteoclastogenesis via MAPK and NF-κB Signaling Pathways |
| topic | Pharmacology (medical), Pharmacology |
| url | http://dx.doi.org/10.3389/fphar.2018.01538 |